Your shopping cart is currently empty

KZR-504 is a selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2) (IC50s: 51 nM, 4.274 μM for LMP2 and LMP7, respectively).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $1,185 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $2,608 | 2-4 weeks | 2-4 weeks |
| Description | KZR-504 is a selective inhibitor of immunoproteasome low molecular mass polypeptide 2 (LMP2) (IC50s: 51 nM, 4.274 μM for LMP2 and LMP7, respectively). |
| Targets&IC50 | LMP7:4.274 μM, LMP2:51 nM |
| In vivo | Assessment of LMP2 inhibition, along with antitargets LMP7 and β5, in mouse tissues indicates that KZR-504 is both selective and potent in vivo. In all tested tissues, except the brain, it achieves over 50% target inhibition at doses exceeding 1 mg/kg [1]. |
| Molecular Weight | 413.42 |
| Formula | C21H23N3O6 |
| Cas No. | 1629052-78-3 |
| Smiles | C[C@@]1(CO1)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)c1cccc(=O)[nH]1 |
| Relative Density. | 1.362 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.